SUSTAINED RELEASE COATING MARKET ANALYSIS

Sustained Release Coating Market, by Polymer Material Type (Polyvinyl & Cellulose Acetate, Ethyl & Methyl Cellulose, Methacrylic Acid, Polyethylene Glycol, and Others), by Substrate (Tablets, Capsules, and Pills), by Application (In Vitro and In Vivo), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI4986
Pages :175
Formats :
Excel and PDF
Industry : Pharmaceutical

Sustained Release Coating MarketSize and Trends

The global sustained release coating market is estimated to be valued at US$ 508.2 Mn in 2021 and is expected to exhibit a CAGR of 6.6% over the forecast period (2021-2028).

Figure 1: Global Sustained Release Coating Market Share (%) Analysis, By Polymer Material Type, 2021

Increasing number of product launches by the market players is expected to drive the growth of the global sustained release coating market over the forecast period.

Increasing approvals from the regulatory authorities is expected to drive the growth of the global sustained release coating market over the forecast period. For instance, on March 26, 2021, Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) approved Myrbetriq (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq Granules (mirabegron for extended-release oral suspension), indicated for the treatment of NDO in pediatric patients aged 3 years and older.